PTGER2-β-Catenin Axis Links High Salt Environments to Autoimmunity by Balancing IFNγ and IL-10 in FoxP3+ Regulatory T cells
Tomokazu SumidaiD, Matthew R. LincolniD, Chinonso M. Ukeje, Donald M. Rodriguez, Hiroshi AkazawaiD, Tetsuo Noda, Atsuhiko T. Naito, Issei KomuroiD, Margarita Dominguez-VillariD, David A. HafleriD
Abstract
Foxp3+ regulatory T cells (Tregs) are the central component of peripheral immune tolerance. While dysregulation of the Treg cytokine signature has been observed in autoimmune diseases such as multiple sclerosis (MS) and type 1 diabetes, the regulatory mechanisms balancing pro- and anti-inflammatory cytokine production are not known. Here, we identify imbalance between IFN{gamma} and IL-10 as a shared Treg signature, present in patients with MS and under high salt conditions. By performing RNA-seq analysis on human Treg subpopulations, we identify {beta}-catenin as a key regulator that controls the expression of IFN{gamma} and IL-10. The activated {beta}-catenin signature is enriched specifically in IFN{gamma}+Tregs in humans, and this was confirmed in vivo with Treg-specific {beta}-catenin-stabilized mice exhibiting lethal autoimmunity with a dysfunctional, IFN{gamma}-producing, Treg phenotype. Moreover, we identify PTGER2 as a major factor balancing IFN{gamma} and IL-10 production in the context of a high salt environment, with skewed activation of the {beta}-catenin/SGK1/Foxo axis in IFN{gamma}+Tregs. These findings identify a novel molecular mechanism underlying inflammatory Tregs in human autoimmune disease and reveal a new role for a PTGER2-{beta}-catenin loop in Tregs linking environmental high salt conditions to autoimmunity.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Coordinated IL-2 and TGF-β Signaling Activates Stable Regulatory T Cells and Promotes Immune Tolerance
Nicholas M. Jackson, Javier A. Carrero, … Richard J. DiPaolo·bioRxiv·Mar 27, 2026
- TLR9-activated B cells improve their regulatory function by endogenously produced catecholamines
N. Honke, T. Lowin, … G. Pongratz·bioRxiv·May 24, 2020
- Regulatory T cells and IFN-γ-producing Th1 cells play a critical role in the pathogenesis of Sjögren's Syndrome
Yin‐Hu Wang, Wenyi Li, … Stefan Feske·Science Translational MedicinePeer-reviewed·Dec 18, 2024
- TIF1γ regulates stability of T regulatory cells during inflammation
Eugenio Contreras-Castillo, Jesús Daniel Zambrano-Romero, … Paula Licona-Limón·Nature ImmunologyPeer-reviewed·Aug 11, 2026
- Overexpression of GITRL by B cell IgD low (BDL) B cells is a therapeutic strategy to increase endogenous CD4+Foxp3+ T regulatory cells for the treatment of autoimmunity
M. I. Khalil, Cody J. Gurski, … Bonnie N. Dittel·bioRxiv·Feb 4, 2025
- Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development
A. Yilmazer, D. M. Zevla, … K. Kretschmer·bioRxiv·Aug 4, 2023